Schedule 13G ownership disclosure

BRIDGEBIO PHARMA INC

Security class unavailable · CUSIP: 09077J107

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-031975
Form type
SC 13G/A
Filer
Bird Global, Inc.
CIK
CIK 1861449
Filed
Feb 09, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G/A | SEC Filings Hub